Free Shipping

on orders over $25

0 item(s) | $0 View Cart

List Price: $35.00

Our Price: $29.75 You Save: $5.25 (15%)

Free Shipping

EMIQ Activated Quercetin - 60 capsules

Image may differ in size, form, flavor, or label.

EMIQ Activated Quercetin

60 Capsules
  • Item #: 9411
  • UPC: 629022094110

Orders Placed by 4:00 PM EST

Ship the Same Day |

List Price: $35.00

Our Price: $29.75 You Save: $5.25 (15%)

Out Of Stock

Add to Wishlist

Quercetin, a dietary flavonol known to be one of the most potent plant-derived antioxidants, has multiple biological actions, with anti-inflammatory, anti-thrombotic and vasodilatory benefits in pre-clinical studies. However, clinical trials have not consistently matched expected results based upon pre-clinical studies.

The limiting factor in quercetin’s clinical efficacy appears to be its poor bioavailability. Enzymatically Modified Isoquercitrin (EMIQ) is a mixture of quercetin monoglucoside and its alpha-oligoglucosides that has been shown to have significantly greater bioavailability than other available forms. In animals, EMIQ was shown to produce a 40 fold increase in Cmax (peak plasma concentration) and an 18-fold increase in the area under the curve compared to quercetin. In humans, EMIQ supplementation increased plasma concentrations to a significantly greater degree than other forms, including aglycone and isoquercitrin, with randomized placebo-controlled trials documenting improvement in allergic symptoms.

EMIQ has also shown significantly enhanced biological activity especially in animal models of allergy and neoplasia. EMIQ has shown significant effects in improving ocular symptoms of hay fever in doubleblind clinical studies. In one study, 20 subjects with hay fever due to Japanese cedar pollinosis took two capsules daily of 100 mg EMIQ or a placebo for 8 weeks during the pollen season. During the entire study period, total ocular score and ocular itching score for the EMIQ group were significantly lower than the placebo group. In another study of hay fever due to Japanese cedar pollinosis, 24 subjects took 100 mg EMIQ or a placebo for 8 weeks, starting 4 weeks prior to the onset of pollen release. During the entire study period, ocular symptom and medication scores for the EMIQ group was significantly lower than the placebo group. When limited to the pollen release period, ocular symptom and ocular congestion scores for the EMIQ group were significantly lower than the placebo group. Other scores for the EMIQ group, such as ocular itching scores, lacrimation scores, and ocular congestion scores, all tended to be lower.

EMIQ Activated Quercetin - Supplement Facts

Suggested Usage: 1–2 capsules per day or as directed by a health care professional. Keep out of reach of children.

Contraindications: No specific contraindications, although safety has not been established during pregnancy/lactation. Patients with impaired renal function should also use with caution.

This product is not available in any additional sizes, forms, or flavors.

There are currently no reviews for this product.

Review This Product

The statements and claims made on this site have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Accutrition Nutritional Consultants® is not liable for the misuse or misinterpretation of any information on this site. Product ingredients and formulations may change over time. We attempt to keep this information up-to-date and accurate, but it is your responsibility to review all product labels before opening. Always consult with your health care practitioner before implementing a diet or supplement regimen.